Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director

Key Terms

semiconductor-based ultrasound devices technical

Medical imaging tools that use semiconductor chips and electronic circuits to create and read ultrasound waves instead of traditional bulky crystal transducers. Think of replacing old-style camera film and mechanical parts with a smartphone sensor: the chip-based approach allows smaller, cheaper, and more easily integrated devices, which matters to investors because it can change manufacturing scale, unit cost, product form factors, and market opportunity while also affecting regulatory and adoption paths.

point-of-care ultrasound medical

Point-of-care ultrasound is a portable imaging tool used by clinicians at the bedside, in clinics or in the field to produce real-time pictures of organs, blood flow or injuries—think of it as a pocket-sized camera for seeing inside the body. It matters to investors because these devices can speed diagnosis, lower costs, shift volumes away from large imaging centers, and create sales and service opportunities for medical device and software companies, affecting growth and margins.

software development kit technical

A software development kit (SDK) is a prepared set of code, tools and instructions that lets other developers build apps or features that work with a company’s product or platform — like giving builders a branded toolbox and blueprint. Investors care because a widely used SDK can grow a product’s ecosystem, speed adoption, create ongoing revenue or lock in customers, and signal whether third parties find the platform easy and valuable to work with.

form 8-k regulatory

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)-- Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, congratulates Dr. Erica Schwartz on her confirmation as director of the Centers for Disease Control and Prevention (CDC). Dr. Schwartz has served as a member of Butterfly Network's Board of Directors since 2021 and has stepped down from the Board effective August 5, 2026 in advance of assuming her new role.

"Erica has been a valued member of our Board and someone I respect as a physician, leader, and colleague. She brings clinical credibility, a genuine commitment to public service, and a passion for what healthcare can be. She's left a lasting mark on Butterfly and we are proud to congratulate her on this well-deserved opportunity. On behalf of the Butterfly community, I thank her deeply for her contributions; we look forward to seeing the impact she'll make in this next chapter," said Joseph DeVivo, President, CEO and Chairman, Butterfly Network.

Additional information regarding Dr. Schwartz's Board service and transition is included in a Form 8-K filed with the U.S. Securities and Exchange Commission.

About Butterfly Network

Butterfly Network, Inc. (NYSE: BFLY) is driving a digital revolution in ultrasound imaging and sensing with its proprietary Ultrasound-on-Chip™ semiconductor technology and software solutions. Butterfly first proved its technology in the point-of-care ultrasound market – commercializing the world's first single-probe, whole-body portable ultrasound device, which is now on its best-selling, third-generation: Butterfly iQ3™. The Company combines its advanced hardware with cloud software and AI, an enterprise workflow solution (Compass AI™) and other offerings to drive adoption of affordable, accessible ultrasound. Butterfly also enables third-party development of imaging AI apps through Butterfly Garden™, its software development kit and AI marketplace.

In addition to its medical imaging products, Butterfly Embedded™ is the Company's Ultrasound-on-Chip™ licensing and co-development business designed to enable a new wave of ultrasound-enabled technologies across non-competitive healthcare markets and beyond. Through Butterfly Embedded™, partners can build and scale novel ultrasound applications powered by Butterfly's proprietary semiconductor chip and software platform.

Butterfly's innovations have been recognized by Prix Galien USA, Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. To learn more, visit: www.butterflynetwork.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260811359591/en/

Investors
John Doherty
Chief Financial Officer, Butterfly
investors@butterflynetwork.com

Media
Liz Snyder
Director, PR & Communications, Butterfly
media@butterflynetinc.com

Source: Butterfly Network, Inc.